Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/EBIT

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 9.7111.3063.7525.3716.03

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 9.71 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar20249.71
Mar202311.30
Mar202263.75
Mar202125.37
Mar202016.03

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37
58.27
Mar2020 16.03 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,910.3 Cr 0.6% -13.7% -40.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,195.0 Cr 0.3% -4% -6.3% Stock Analytics
DIVIS LABORATORIES ₹159,417.0 Cr 2% -9.6% 33.1% Stock Analytics
CIPLA ₹124,867.0 Cr 1.9% 4.5% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,971.0 Cr 0.6% 3.6% 9.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,956.0 Cr 2% -1% -7% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.6%

-13.7%

-40.3%

SENSEX

2%

0.1%

1.8%


You may also like the below Video Courses